Breakthrough drug offers hope for children with Achondroplasia
Promising Results in Height Growth and Reduced Health Risks In a groundbreaking study led by the Murdoch Children’s Research Institute (MCRI), a drug called vosoritide, designed to boost bone growth in children with the most common form of dwarfism (achondroplasia), has shown remarkable potential beyond its...
07 December, 2023